亚历山大(ALX)
搜索文档
Alexander's Is A Good Business That The Market Has Overestimated
Seeking Alpha· 2024-11-12 19:00
An economics graduate with a passion for financial history; I apply my knowledge to markets in an effort to hopelessly predict trends and spot value. All opinions are my own and should not be taken seriously.Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ...
ALX Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire News Room· 2024-11-08 05:00
SOUTH SAN FRANCISCO, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer in new ways and extend patients’ lives, today reported financial results for the third quarter ended September 30, 2024, and provided a corporate update. “We made substantial clinical progress during the third quarter, most notably announcing topline data from our AS ...
Alexander's (ALX) Tops Q3 FFO and Revenue Estimates
ZACKS· 2024-11-04 23:55
Alexander's (ALX) came out with quarterly funds from operations (FFO) of $2.84 per share, beating the Zacks Consensus Estimate of $2.57 per share. This compares to FFO of $3.63 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an FFO surprise of 10.51%. A quarter ago, it was expected that this real estate investment trust would post FFO of $2.57 per share when it actually produced FFO of $3.31, delivering a surprise of 28.79%.Over the last four quarter ...
Alexander's Announces Third Quarter Financial Results
GlobeNewswire News Room· 2024-11-04 22:16
PARAMUS, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- ALEXANDER’S, INC. (New York Stock Exchange: ALX) filed its Form 10-Q for the quarter ended September 30, 2024 today and reported: Third Quarter 2024 Financial Results Net income for the quarter ended September 30, 2024 was $6.7 million, or $1.30 per diluted share, compared to $10.8 million, or $2.10 per diluted share for the quarter ended September 30, 2023. Funds from operations (“FFO”) (non-GAAP) for the quarter ended September 30, 2024 was $14.6 million, o ...
Alexander’s(ALX) - 2024 Q3 - Quarterly Report
2024-11-04 21:31
财务业绩 - 公司第三季度净收入为6,678,000美元,每股摊薄收益为1.30美元[67] - 公司第三季度基金营运收益(FFO,非GAAP)为14,582,000美元,每股摊薄收益为2.84美元[67] - 公司第三季度租金收入为55,675,000美元,较上年同期增加262,000美元[78] - 公司第三季度运营费用为26,446,000美元,较上年同期增加853,000美元[79] - 公司第三三季度利息和债务费用为19,261,000美元,较上年同期增加3,086,000美元[83] - 公司第三季度利息和其他收入为6,105,000美元,较上年同期减少517,000美元[82] - 公司2024年9个月的FFO为57,123,000美元,同比增长3%[102] - 公司2024年9个月的FFO每股收益为11.13美元,同比增长3%[102] 资产负债管理 - 公司于2024年6月11日将731 Lexington Avenue物业的5亿美元贷款展期4个月并偿还1,000万美元本金[70] - 公司于2024年9月30日为731 Lexington Avenue物业的办公部分签订了4亿美元的新贷款,利率为5.04%,到期日为2028年10月[71] - 截至2024年9月30日的9个月现金及现金等价物和受限现金为397,176,000美元,较2023年12月31日的552,977,000美元减少155,801,000美元[93] - 2024年9个月经营活动产生的现金净流入为23,296,000美元,其中包括净收入31,167,000美元和非现金项目调整45,349,000美元[93] - 2024年9个月投资活动使用的现金净额为3,273,000美元,主要用于在建工程和房地产添置9,836,000美元[93] - 2024年9个月筹资活动使用的现金净额为175,824,000美元,主要包括偿还债务500,000,000美元和支付股利69,277,000美元[93] 资产处置 - 公司于2023年5月19日以7,106万美元的价格出售了Rego Park III地块,获得净收益6,782.1万美元[72] 风险管理 - 公司持有1.7亿美元的一般责任险和财产险额度,其中30,000,000美元包括传染病保险[96] - 公司的全资子公司Fifty Ninth Street Insurance Company, LLC为恐怖主义行为(包括核生化武器)提供高达17亿美元的保险[97] 主要租户风险 - 公司主要租户彭博社(Bloomberg)占公司租金收入的55%,如果失去该租户将对公司业绩产生不利影响[75]
ALX Oncology Announces Results from Phase 1b/2 Trial of Evorpacept in Combination with Zanidatamab will be Presented at the San Antonio Breast Cancer Symposium (SABCS) 2024
GlobeNewswire News Room· 2024-11-02 05:30
SOUTH SAN FRANCISCO, Calif., Nov. 01, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer in new ways and extend patients’ lives, today announced that results from a Phase 1b/2 combination trial evaluating ALX Oncology’s evorpacept in combination with Jazz Pharmaceuticals’ zanidatamab in HER2-positive and HER2-low metastatic breast cancer have been accept ...
Alexander's Announces Third Quarter Earnings Release Date and Vornado Realty Trust Quarterly Conference Call
GlobeNewswire News Room· 2024-10-23 01:45
PARAMUS, N.J., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Alexander’s, Inc. (NYSE: ALX) today announced that it will file its quarterly report on Form 10-Q for the quarter ended September 30, 2024 with the U.S. Securities and Exchange Commission and issue its third quarter earnings release on Monday, November 4, 2024, before the New York Stock Exchange opens. Vornado Realty Trust (NYSE: VNO), the manager which conducts Alexander’s operations, announced it will host its quarterly earnings conference call and an audio ...
Greenridge Exploration Enters into Binding Arrangement Agreement to Acquire ALX Resources Corp.
Newsfile· 2024-10-12 02:12
Greenridge Exploration Enters into Binding Arrangement Agreement to Acquire ALX Resources Corp.NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESOctober 11, 2024 2:12 PM EDT | Source: ALX Resources Corp.Vancouver, British Columbia--(Newsfile Corp. - October 11, 2024) - Greenridge Exploration Inc. (CSE: GXP) (FSE: HW3) ("Greenridge" or the "Company") and ALX Resources Corp. ("ALX" and collectively with Greenridge, the "Parties") (TSXV: AL) (FSE: 6 ...
Alexander's Completes $400 Million Refinancing of 731 Lexington Avenue Office Condominium
GlobeNewswire News Room· 2024-10-01 04:27
PARAMUS, N.J., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Alexander’s, Inc. (NYSE: ALX) today announced that it has completed a $400 million refinancing of the office condominium portion of 731 Lexington Avenue, the Class A Bloomberg LP headquarters building. The interest-only loan carries a fixed rate of 5.045% and matures in October 2028. The loan is prepayable, at Alexander’s option, with no penalty, beginning in October 2026. The loan replaces the prior $490 million loan on the office condominium, that bore int ...
Best Income Stocks to Buy for September 18th
ZACKS· 2024-09-18 21:50
Here are three stocks with buy rank and strong income characteristics for investors to consider today, September 18th:Alexander's (ALX) : This real estate investment trust which is engaged in leasing, managing, developing and redeveloping properties, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 15.5% over the last 60 days.This Zacks Rank #1 (Strong Buy) company has a dividend yield of 7.4%, compared with the industry average of 4.2%.J. Sainsbury (JSAIY) : This leading ...